Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume 115, Issue 7, Pages 1688-1698Publisher
AMER SOC CLINICAL INVESTIGATION INC
DOI: 10.1172/JCI25669
Keywords
-
Categories
Funding
- NIAID NIH HHS [AI31971, R01 AI031971, R56 AI031971] Funding Source: Medline
Ask authors/readers for more resources
Human parainfluenza viruses cause severa; serious respiratory diseases in children for which there is no effective preventation or therapy. Parainfluenza viruses initiate infection by binding to cell surface receptors and then, via coordinated action of the 2viral surface glycoproteins, fuse directly with the cell membrane to release the viral replication machinery into the host cell's cytoplasm. During this process, the receptor-binding molecule must trigger the viral fusion protein to mediate fusion and entry of the virus into a cell. This review explores the binding and entry into cells of parainfluenza virus type 3, focusing on how the receptor-binding molecule triggers the fusion process. There are several steps during the process of binding, triggering, and fusion that are now understood at the molecular level, and each of these steps represents potential targets for interrupting infection.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available